ADIPOQ and hepatocellular carcinoma: Furthermore, a higher circulating adiponectin seems to be related not only with an increased risk of HCC, but also with a poor survival of HCC patients based on the findings of a prospective study of 140 HCC patients, being followed-up for approximately 8 months [74].